Moneycontrol
HomeNewsBusinessCompaniesLipitor is biggest catalyst to Ranbaxy's growth: Expert
Trending Topics
LG Electronics IPO Allotment Status
Canara HSBC Life IPO GMP
Midwest IPO Price
WeWork Share Price
Silver ETF

Lipitor is biggest catalyst to Ranbaxy's growth: Expert

Chirag Talati, pharma analyst at Espirito Santo Securities tells CNBC-TV18 that Ranbaxy is most likely set to go ahead with the launch of the generic version of Lipitor, but how much market share it commands needs to be watched.

November 30, 2011 / 12:32 IST
Story continues below Advertisement
Remove Ad

Your browser doesn't support HTML5 video.

Ranbaxy is down nearly 3% at Rs 437 today. The market seems to have apprehensions about what will eventually happen with the company

TAGS: #Business #exclusive rights #FDA #largest selling drug #Lipitor #Ranbaxy #US FDA
first published: Nov 30, 2011 11:55 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.